Clinical advancement in the management of mutant isocitrate dehydrogenase (<i>IDH</i>) cancers.
- DOI
- 10.1016/j.ejcsup.2025.12.001
- Published
- 2026-03-27
- Container
- EJC Suppl
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejcsup.2025.12.001,
title = {Clinical advancement in the management of mutant isocitrate dehydrogenase (\<i\>IDH\</i\>) cancers.},
author = {Bridgewater J and Tabatabai G and Macarulla T and Stacchiotti S.},
year = {2026},
journal = {EJC Suppl},
doi = {10.1016/j.ejcsup.2025.12.001},
url = {https://doi.org/10.1016/j.ejcsup.2025.12.001}
}RIS
TY - JOUR TI - Clinical advancement in the management of mutant isocitrate dehydrogenase (<i>IDH</i>) cancers. AU - Bridgewater J AU - Tabatabai G AU - Macarulla T AU - Stacchiotti S. PY - 2026 JO - EJC Suppl DO - 10.1016/j.ejcsup.2025.12.001 UR - https://doi.org/10.1016/j.ejcsup.2025.12.001 ER -
APA
J, B., G, T., T, M., & S., S. (2026). Clinical advancement in the management of mutant isocitrate dehydrogenase (<i>IDH</i>) cancers.. EJC Suppl. https://doi.org/10.1016/j.ejcsup.2025.12.001
Source records
- europe-pmc · retrieved 2026-09-25T19:25:00.832Z
- doaj · retrieved 2026-09-25T19:25:00.821Z